metformin has been researched along with cyproterone in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Harrison, C; Hutchison, SK; Meyer, C; Stepto, N; Teede, HJ | 1 |
| Bao, WF; Zhang, T; Zhao, H | 1 |
| Fruzzetti, F; Gambacciani, M; Genazzani, AR; Lazzarini, V; Parrini, D; Perini, D | 1 |
| Aleksandrowicz-Wrona, E; Dardzińska, JA; Kuligowska-Jakubowska, M; Lysiak-Szydłowska, W; Płoszyński, A; Rachoń, D; Wyrzykowski, B | 1 |
4 trial(s) available for metformin and cyproterone
| Article | Year |
|---|---|
Retinol-binding protein 4 and insulin resistance in polycystic ovary syndrome.
Topics: Adult; Body Mass Index; Contraceptives, Oral; Cyproterone; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin Resistance; Metformin; Overweight; Polycystic Ovary Syndrome; Retinol-Binding Proteins, Plasma; Waist-Hip Ratio | 2008 |
[Advantages of Chinese medicine for treatment of blood sugar and lipid metabolic disorders in patients with polycystic ovarian syndrome].
Topics: Adolescent; Adult; Blood Glucose; Cholesterol, HDL; Cyproterone; Drugs, Chinese Herbal; Female; Humans; Insulin; Insulin Resistance; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Metabolic Diseases; Metformin; Polycystic Ovary Syndrome; Young Adult | 2009 |
Comparison of effects of 3 mg drospirenone plus 20 μg ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with polycystic ovary syndrome.
Topics: Administration, Oral; Adolescent; Adult; Androgens; Androstenes; Blood Pressure; Cardiovascular Diseases; Cyproterone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Glucose; Humans; Hypoglycemic Agents; Insulin; Lipids; Metformin; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Risk Factors; Young Adult | 2010 |
Effects of metformin or an oral contraceptive containing cyproterone acetate on serum c-reactive protein, interleukin-6 and soluble vascular cell adhesion molecule-1 concentrations in women with polycystic ovary syndrome.
Topics: Adolescent; Adult; Androgen Antagonists; C-Reactive Protein; Contraceptives, Oral; Cross-Sectional Studies; Cyproterone; Female; Follow-Up Studies; Humans; Hypoglycemic Agents; Interleukin-6; Metformin; Polycystic Ovary Syndrome; Time Factors; Vascular Cell Adhesion Molecule-1 | 2014 |
2 other study(ies) available for metformin and cyproterone
| Article | Year |
|---|---|
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |